Oncology & Cancer

Protein disguise could be new target for cancer immunotherapy

Researchers at the Francis Crick Institute have identified a protein that helps tumors evade the immune system and, in certain types of cancers, is linked to a poorer chance of survival. The protein could become a target ...

Diseases, Conditions, Syndromes

Good news: Mild COVID-19 induces lasting antibody protection

Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University ...

Gerontology & Geriatrics

Gut microbiome implicated in healthy aging and longevity

The gut microbiome is an integral component of the body, but its importance in the human aging process is unclear. ISB researchers and their collaborators have identified distinct signatures in the gut microbiome that are ...

Oncology & Cancer

Anti-cancer drug's mode of operation deciphered

Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery about how it works. ...

Diseases, Conditions, Syndromes

S.Africa virus strain poses 're-infection risk': study

The coronavirus variant detected in South Africa poses a "significant re-infection risk" and raises concerns over vaccine effectiveness, according to preliminary research Wednesday, as separate studies suggested the British ...

Neuroscience

Study measures brain volume differences in people with HIV

Nearly 38 million people around the world are living with HIV, which, with access to treatment, has become a lifelong chronic condition. Understanding how infection changes the brain, especially in the context of aging, is ...

Diseases, Conditions, Syndromes

SARS-CoV-2 antibodies provide lasting immunity

One of the most significant questions about the novel coronavirus is whether people who are infected are immune from reinfection and, if so, for how long.

Diseases, Conditions, Syndromes

Study hints, can't prove, survivor plasma fights COVID-19

Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it's not proof and some experts worry if, amid clamor for the treatment, they'll ever get a clear ...

page 4 from 30